3
and Tim50. Top: Relative gene expression was measured by qRT-PCR (n=3). Values are reported as means ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 versus negative. given free access to a pellet diet and purified water ad libitum. Experiments were performed after an acclimatization period of 4 days.
Surgery
The rats were anesthetized with pentobarbital sodium, then two polyethylene catheters (0.1-mm diameter) filled with heparinized saline were annulated into the left femoral artery and vein to allow for continuous recording of arterial blood pressure, collection of blood samples, and controlled bleeding. MAP and ECG readings were continuously monitored with a polygraph (Biopac Systems, Inc., M150A). The rats were observed for 10 minutes after surgery to ensure stability of the MAP and ECG.
Body temperature was carefully maintained at 37 ± 0.5ºC using a heating pad (Softron, TMS-201). MAP was monitored at a minimum of 30 minutes after hemorrhage until the rats showed initial signs of recovery from anesthesia, and then the femoral catheters were removed. The skin over the incision sites was carefully closed by sutures and covered with antibiotic ointment. OCR was measured using the Seahorse XFe96 analyser. After the hemorrhage procedures were completed, the rats were kept under observation in heated cages at 37°C with free access to diet pellets and purified water. Exclusion criteria were as follows: MAP < 100 mmHg before hemorrhage, surgical bleeding > 0.5 ml during catheterization, and surgical time > 15 minutes.
Hemorrhage procedures
Hemorrhage was performed using adjustable pumps (Lange Corporation). For phase 1 (P1) hemorrhage, 40% volume of whole blood was rapidly withdrawn from the femoral artery over 10 minutes. For phase 2 (P2) hemorrhage, the femoral vein was allowed to bleed another 20% of total blood over the next 50 minutes to simulate the process of a chronic bleeding stage. Animals were randomly assigned to different groups; VPA was dissolved in 0.9% saline (250 µl) and administered through the right femoral vein. The first hemorrhage model included groups treated at the end of P1, the second hemorrhage model treated at the end of P2.
Groups
The first hemorrhage model included groups treated with VPA at the end of P1 (10 min 
Western blotting and immunoprecipitation
For immunoblot analysis, rat tissues and cells were lysed in a lysis buffer (50 mM Tris at pH7.4, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA) and protease inhibitor cocktail (Roche) on ice. well XF plate and grown in standard DMEM medium with 15% FBS, incubating overnight at 37°C in 5% CO 2 atmosphere. For oxygen consumption rate measurement, growth medium was replaced with XF assay medium. The cells were pre-incubated at 37°C for 1 hour before starting the analysis. Oligomycin was used at a final concentration of 2µM, FCCP at 0.5µM, Antimycin A and Rotenone at 0.5µM.
Mitochondrial microscopy imaging
MCL-1 over-expression and siRNA knockdown H9c2 cells were cultured in DMEM supplemented with 15% FBS and incubated overnight. The cell culture media was then replaced by hypoxic medium (obtained by DMEM media supplement with 2 mM CoCl2 solution) and cultured for additional 6h to induce hypoxic injury.
PCMV6-Entry and non-targeting siRNA transfected H9c2 cells were applied as control respectively. The hypoxic medium was replaced by the serum-free pre-warmed media containing Mitochondrion-Selective Probes (MitoTracker® Green 16 FM), incubation for 30 minutes under cell growth conditions. After staining is complete, replace the staining solution with fresh prewarmed media with or without VPA, and observe cells using a DeltaVision Microscopy Imaging Systems (Applied Precision) using 10 min frames during 12 hours.
